| Literature DB >> 36126067 |
Anton Delport1, Hanani Tabana1, Lucia Knight1,2, Edwin Wouters3.
Abstract
INTRODUCTION: The scale-up of access to antiretroviral therapy has transformed HIV from an acute, terminal disease to a manageable chronic illness. Yet, sustaining high levels of antiretroviral therapy adherence remain a challenge, especially in the sub-Saharan Africa region which is disproportionately affected by HIV. This protocol proposes a scoping review to explore literature reporting on the antiretroviral therapy adherence levels among people who experience substance abuse and violence (SAVA) syndemics, as well as mood disorders such as anxiety and depression among people living with HIV in sub-Saharan Africa. METHODS AND ANALYSIS: This proposed scoping review will follow Arksey and O'Malley's methodological framework for conducting scoping reviews as refined by Levac et al. The review will follow the Joanna Briggs Institute's manual for conducting scoping reviews. Literature searches will be conducted using six databases: Academic search complete; APA PsycArticles; CINAHL; MEDLINE; SocINDEX and Web of science. Title screening will see the "Participant, Concept, Context" framework applied to identify relevant literature and will not include the appraisal of search results. Data charting will follow an adapted version of Trico and colleagues' PRISMA-ScR and results will be mapped descriptively and in tabular format. Furthermore, results will be discussed within the syndemics model of health, and summarised as a biosocial conceptual model. ETHICS AND DISSEMINATION: The study will make use of secondary data that are readily available to the public and will not require ethical approval. We intend to publish our results in a peer-reviewed journal and disseminate our findings at relevant conferences and seminars.Entities:
Mesh:
Year: 2022 PMID: 36126067 PMCID: PMC9488813 DOI: 10.1371/journal.pone.0274614
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1PRISMA-ScR [29].
Population- concept-context framework [28].
| Components | Definition | Study |
|---|---|---|
| Population | Important characteristics (including age and other qualifying factors) | People living with HIV who have initiated ART (no age restriction, includes at-risk populations) |
| Concepts | A clear definition of the key concepts (including the scope and breadth of the search) | ART adherence behaviour, violence, substance use, anxiety, depression, SAVA syndemic |
| Context | Broad (including cultural, geographic, gender, racial or population factors) | Sub-Sahara Africa (impoverished settings) |
Research questions and intended outcomes.
|
|
|
| What is the impact of concurrent occurring SAVA syndemics and mood disorders, manifested as anxiety and depression, on ART adherence behaviour among PLWH in the SSA region? | A conceptual syndemics model to inform the conceptualisation around the co-occurrence of SAVA syndemics and poor mental health among PLWH who have initiated ART (-who reside in the SSA region). |
|
|
|
| How prevalent is the SAVA syndemic among PLWHA on ART in SSA? | Prevalence levels/descriptives of mutually occurring SAVA syndemics among PLWH who have initiated ART (-who reside in the SSA region). |
| How prevalent is the coexistence of the SAVA syndemic and depression and/or anxiety among PLWH on ART in SSA? | Prevalence levels/descriptives of mutually occurring SAVA syndemics and depression and/or anxiety among PLWH who have initiated ART (-who reside in the SSA region). |
| What is the impact of the SAVA syndemic on ART adherence in SSA? | Tabular mapping detailing the impact which SAVA syndemics has on ART adherence among PLWH who have initiated ART (-who reside in the SSA region). |
| What is the impact of depression and/or anxiety on ART adherence? | Tabular mapping detailing the impact of depression and/or anxiety on ART adherence among PLWH who have initiated ART ART (-who reside in the SSA region). |
Database, field and boolean search strings.
| Databases | Field | Boolean combinations |
|---|---|---|
|
| Title | HIV AND (violence OR abuse OR gender-based violence OR GBV OR intimate partner violence OR IPV AND depress* OR anxiety OR mood disorder*) OR (substance* OR drug* OR addict* OR people who inject drugs OR PWID* OR SAVA AND depress* OR anxiety OR mood disorder*) AND (association OR relationship) AND (antiretroviral OR antiretroviral therapy OR HAART AND adhere*) AND (sub Saharan Africa OR SSA OR Angola OR Benin OR Botswana OR Burkina Faso OR Burundi OR Cabo Verde OR Cameroon OR Central African Republic OR Chad OR Comoros OR Congo OR Cote d’Ivoire OR Equatorial Guinea OR Eritrea OR Ethiopia OR Gabon OR Gambia OR Ghana OR Guinea OR Guinea-Bissau OR Kenya OR Lesotho OR Liberia OR Madagascar OR Malawi OR Mali OR Mauritania OR Mauritius OR Mozambique OR Namibia OR Niger OR Nigeria OR Rwanda OR Sao Tome and Principe OR Senegal OR Seychelles OR Sierra Leone OR Somalia OR South Africa OR South Sudan OR Sudan OR Tanzania OR Togo OR Uganda OR Zambia OR Zimbabwe) |
|
| Abstract | |
|
| Title | |
|
| Title | |
|
| Title | |
|
| Title |
Fig 2PRIMSA flowchart.